Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.
about
Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian responsePharmacogenetics of follicle-stimulating hormone actionThe Asn680Ser polymorphism of the follicle stimulating hormone receptor gene and ovarian cancer risk: a meta-analysis.FSHR single nucleotide polymorphism frequencies in proven fathers and infertile men in Southeast Turkey.p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patientsPET of follicle-stimulating hormone receptor: broad applicability to cancer imagingThe relationship between fertility and lifespan in humans.Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene studyGenetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.Phenotypic and pharmacogenetic aspects of ovulation induction in WHO II anovulatory women.TrkB as a therapeutic target for ovarian cancer.Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.Expression and purification of the extracellular domain of the human follicle-stimulating hormone receptor using Escherichia coli.Effect of Follicle Stimulating Hormone Receptor Gene Polymorphisms in Cervical Cancer Risk.
P2860
Q24289192-92408574-80EA-4324-B0C4-2E3EEB8BF654Q27009516-206CA0D6-0123-4DFA-B099-B5953D708CA5Q33721988-619EB75B-39DC-4FB8-822A-638CBE455140Q33821470-F4063740-99BE-416A-A5A0-CA4CCD48D4DBQ34276605-13A90E51-7438-403F-B289-261A46837B26Q35153873-9CDF0A71-12EF-4A5C-BBC7-E0E1BAAAE014Q35562296-F3AC3DD7-7E85-4AA3-BBB1-D0CCDB8248EDQ36966218-FD1CD3D0-DC06-4185-850C-CD45B7572AB0Q37192456-909FA1AF-9C91-4AD2-9760-C082BA77097AQ37466378-87CE7E25-5774-4CA9-926C-25C6453E4310Q37582910-55773190-97D8-49CD-9E15-A4119325D4F1Q37931055-77F6D8BA-A7BA-4DE4-BE3E-1B4CCBE3A74DQ38890369-6324748E-A233-43D4-8642-33D1B0CE9DB6Q39781669-6A92D01E-5E2B-47EB-9D25-E75F3AB47453Q44157086-4CCC2EBA-4852-49EB-80F0-0623A616D6F4Q46602760-1C2C18DD-FA34-406E-B2F5-F369BD7769F0
P2860
Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Single nucleotide polymorphism ...... ovarian cancer susceptibility.
@en
Single nucleotide polymorphism ...... ovarian cancer susceptibility.
@nl
type
label
Single nucleotide polymorphism ...... ovarian cancer susceptibility.
@en
Single nucleotide polymorphism ...... ovarian cancer susceptibility.
@nl
prefLabel
Single nucleotide polymorphism ...... ovarian cancer susceptibility.
@en
Single nucleotide polymorphism ...... ovarian cancer susceptibility.
@nl
P2093
P2860
P356
P1433
P1476
Single nucleotide polymorphism ...... ovarian cancer susceptibility.
@en
P2093
P2860
P304
P356
10.1093/CARCIN/BGL014
P407
P577
2006-03-30T00:00:00Z